We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$33.9B
AUM Growth
-$12.9B
(-28%)
Cap. Flow
-$11.3B
Cap. Flow
% of AUM
-33.44%
Top 10 Holdings %
Top 10 Hldgs %
7.18%
Holding
4,846
New
656
Increased
881
Reduced
976
Closed
2,305
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 14.66% |
| 3 | Industrials | 10.19% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STSA
2326
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $194K | ﹤0.01% |
51,074
-47,873
| -48% | -$216K |
|
|
MACK
2327
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $194K | ﹤0.01% |
30,739
-5,227
| -15% | -$29.4K |
|
|
SY
2328
So-Young International
SY
$227M
| $192K | ﹤0.01% |
97,089
+50,427
| +108% | +$121K |
|
2329
Colony Bankcorp
CBAN
$464M
| $191K | ﹤0.01% |
10,252
-601
| -6% | -$10.8K |
|
2330
Full House Resorts
FLL
$90.9M
| $191K | ﹤0.01% |
19,900
-166,273
| -89% | -$1.54M |
|
|
SQZ
2331
DELISTED
SQZ Biotechnologies Company
SQZ
| $191K | ﹤0.01% |
39,692
-7,489
| -16% | -$47.5K |
|
2332
KLX Energy Services
KLXE
$45.8M
| $189K | ﹤0.01% |
+36,601
| New | +$223K |
|
|
NNDM
2333
Nano Dimension
NNDM
$347M
| $189K | ﹤0.01% |
+52,996
| New | +$191K |
|
|
REE
2334
DELISTED
REE Automotive
REE
| $185K | ﹤0.01% |
+3,238
| New | +$330K |
|
|
NMTR
2335
DELISTED
9 Meters Biopharma
NMTR
| $183K | ﹤0.01% |
15,264
-560
| -4% | -$7.65K |
|
|
GTHX
2336
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $182K | ﹤0.01% |
23,885
-112,350
| -82% | -$1.07M |
|
2337
Imunon
IMNN
$6.81M
| $180K | ﹤0.01% |
2,723
+1,157
| +74% | +$90.8K |
|
2338
CVRx
CVRX
$62.6M
| $178K | ﹤0.01% |
+29,694
| New | +$240K |
|
2339
Energy Vault
NRGV
$607M
| $178K | ﹤0.01% |
+11,187
| New | +$128K |
|
|
RGF
2340
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $177K | ﹤0.01% |
1,865
-1,790
| -49% | -$141K |
|
2341
Anghami
ANGH
$33.3M
| $175K | ﹤0.01% |
+2,000
| New | +$257K |
|
|
NINE
2342
DELISTED
Nine Energy Service
NINE
| $173K | ﹤0.01% |
+46,244
| New | +$87.1K |
|
2343
Perimeter Solutions
PRM
$5.65B
| $172K | ﹤0.01% |
14,214
-63,183
| -82% | -$794K |
|
2344
Sigma Lithium
SGML
$1.32B
| $172K | ﹤0.01% |
+12,641
| New | +$138K |
|
|
ELVT
2345
DELISTED
Elevate Credit, Inc.
ELVT
| $170K | ﹤0.01% |
55,507
-143,783
| -72% | -$452K |
|
|
ALJJ
2346
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $169K | ﹤0.01% |
+64,339
| New | +$144K |
|
|
IRD
2347
Opus Genetics
IRD
$303M
| $168K | ﹤0.01% |
51,700
-68,200
| -57% | -$233K |
|
|
MAG
2348
DELISTED
MAG Silver
MAG
| $166K | ﹤0.01% |
+10,253
| New | +$163K |
|
2349
TORM
TRMD
$2.99B
| $166K | ﹤0.01% |
18,700
-1,100
| -6% | -$8.68K |
|
|
CARV
2350
DELISTED
Carver Bancorp
CARV
| $163K | ﹤0.01% |
23,252
-3,247
| -12% | -$24.6K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Investments held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Two Sigma Investments withdrew a net $11.3B in Q1 2022, closing 2,305 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Two Sigma Investments opened a new position in Cisco worth $223M.
- Two Sigma Investments's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- Two Sigma Investments added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- Two Sigma Investments's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- Two Sigma Investments fully exited Pfizer in Q1 2022, selling an estimated $271M.
- Two Sigma Investments's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- Two Sigma Investments opened 656 new positions and closed 2,305 in Q1 2022.
- Two Sigma Investments's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.